Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

CVS and IBM commit $1.5M to promote innovation in community health centers

CVS Caremark Charitable Trust, IBM and the National Association of Community Health Centers announced a $1.5 million commitment to a grant program designed to support the use of innovative technology in community health centers.

Inefficient communication costs average U.S. hospital $1.75M

Inefficient communication during patient admissions, emergency response team coordination and patient transfers costs the average U.S. hospital about $1.75 million annually, according to a report from Ponemon Institute and Imprivata.

Thumbnail

Patient-generated data in comparative effective research will enhance quality of care

Patient-generated data and comparative effectiveness research hold the key to greatly improving both individual and population health, according to a study published in Health Affairs.

Thumbnail

New York provider consortium takes aim at Medicaid costs, and state grant money

More than 200 community-based organizations that provide various health services across the 14-county area around Rochester, New York, are teaming up to identify ways to reduce the state’s Medicaid costs while improving care quality. Along the way, they also hope to win some of the state’s Delivery System Reform Incentive Payment program, or DSRIP, $8-billion waiver from the Centers for Medicare and Medicaid Services.

Thumbnail

Detroit Medical Center wins +$9 million HHS Innovation Award to test putting primary care adjacent to ED

Detroit Medical Center and Vanguard Health have won a $9,966,608 Department of Health an Human Services (HHS) Health Care Innovation Award to test what might happen to emergency department utilization if patient-centered medical home clinics are established next to four major inner-city emergency departments (EDs) and used to make primary care immediately available to individuals who arrive at the EDs for non-urgent care.

Thumbnail

New government funding tackles primary care shortage

The Department of Health and Human Services (HHS) announced this week that it will put nearly $200 million toward community health center expansion funding and primary care physician training, as well as funding new health innovation projects that address primary care. But it is unlikely to make a sizeable dent in the primary care shortage, notes the grassroots advocacy group Primary Care Progress.

Tufts Medical Center Automates Anesthesia Record with Plexus Information Systems' AIMS

BOSTON, July 8, 2014--Plexus Information Systems, Inc. (Plexus IS), a market-leading provider of Anesthesia Information Management Systems (AIMS), announced today that Tufts Medical Center went live with Anesthesia Touch™, a full-featured AIMS that automates the anesthesia documentation process.

NextGen Healthcare and HMC/CAH Consolidated, Inc. Expand Relationship

HORSHAM, Pa.--NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today it has forged an agreement with HMC/CAH Consolidated, Inc. (HMC). NextGen’s solutions will be deployed at five of HMC’s wholly owned Critical Access Hospitals; bringing 10 of HMC’s 12 rural community-based hospitals onto the NextGen Healthcare platform.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.